Donor-derived CD7 CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor-derived CD7 CAR-T therapy, covering 2025-11-26 to 2025-11-26. Get the full timeline:
Most recent: Clinical Trial Update: Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies [Phase 1, Phase 2]